Myobloc Market Report 2026

Myobloc Market Overview

• The Myobloc market growth in the historic period has been driven by increasing diagnosis of cervical dystonia, wider clinical acceptance of botulinum toxin therapies • Market expansion is supported by increasing adoption of targeted neuromodulation therapies, expansion of indications for botulinum toxins • Growth Driver: Rising Prevalence Of Neuromuscular Disorders Driving The Growth Of The Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Myobloc Market?

Myobloc, also known as rimabotulinumtoxinB, is an injectable formulation of botulinum toxin type B. It is mainly used to treat adults with cervical dystonia, a condition that causes involuntary neck muscle contractions, and chronic sialorrhea, or excessive drooling. By blocking nerve signals to targeted muscles or glands, Myobloc helps alleviate these symptoms. The main indications for myobloc are chronic sialorrhea, cervical dystonia, and other neurological disorders. Chronic sialorrhea is a condition characterized by excessive drooling or salivation that persists over time. The distribution channels include hospitals, specialty clinics, dermatology clinics, and home healthcare services. The formulations available for myobloc are injectable solution and lyophilized powder for reconstitution. End users are adult patients and pediatric patients.

What Is The Myobloc Market Growth Forecast?

The growth in the forecast period can be attributed to increasing adoption of targeted neuromodulation therapies, expansion of indications for botulinum toxins, growing aging population with neurological disorders, rising investments in specialty biologics, increasing demand for long-acting injectable formulations. Major trends in the forecast period include increasing adoption of botulinum toxin type b therapies, rising demand for non-surgical neurological treatments, growing use in chronic sialorrhea management, expansion of specialty neurology and movement disorder clinics, enhanced focus on symptom-specific therapeutics.

Global Myobloc Market Segmentation

1) By Indication: Chronic Sialorrhea, Cervical Dystonia, Other Neurological Disorders 2) By Distribution Channel: Hospital, Specialty Clinics, Dermatology Clinics, Home Healthcare Services 3) By Formulation: Injectable Solution, Lyophilized Powder For Reconstitution 4) By End User: Pediatric Patients

What Are The Drivers Of The Myobloc Market?

The rising prevalence of neuromuscular disorders is expected to propel the growth of the myobloc market going forward. Neuromuscular disorders encompass a range of conditions that impair the functioning of the muscles and the nerves controlling them, leading to symptoms such as muscle weakness, spasms, and loss of coordination. The rising prevalence of neuromuscular disorders can be attributed to factors such as an aging population, improved diagnosis, and genetic factors, which have led to better identification and reporting of these conditions. Myobloc is proven effective in treating neuromuscular disorders, including blepharospasm (involuntary contractions of the eye muscles) and hemifacial spasm, by alleviating abnormal muscle contractions and providing relief. For instance, in July 2024, according to the National Health Service (NHS) England, a UK-based government department, multiple sclerosis affects over 150,000 people in the UK, with more than 120,000 in England, and is more prevalent in women. Each week, approximately 135 new diagnoses are made, highlighting its significant impact on the population. Therefore, the rising prevalence of neuromuscular disorders is driving the growth of the myobloc industry. The growing demand for non-surgical treatments are expected to drive the expansion of the myobloc market going forward. The growing demand for non-surgical treatments is driven by factors such as lower risk, greater convenience, and the aging population seeking effective, minimally invasive options for maintaining health and appearance. Myobloc is utilized in non-surgical treatments for aesthetic procedures, offering a minimally invasive solution for reducing wrinkles and enhancing facial appearance. For instance, in August 2023, according to The Aesthetic Society, a US-based organization of plastic surgery and cosmetic medicine, Americans spent more than $11.8 billion on aesthetic procedures overall, up 2% from the previous year. Therefore, the growing demand for non-surgical treatments are driving the growth of the myobloc industry. The increasing cases of chronic pain conditions are expected to drive the growth of the myobloc market in the coming years. Chronic pain conditions refer to long-lasting pain that persists for months or years, often extending beyond the typical recovery time from an injury or illness. The increasing cases of chronic pain conditions can be attributed to several factors, including the aging population, sedentary lifestyle, and obesity. Myobloc is effective in treating conditions such as cervical dystonia and other movement disorders by blocking the release of acetylcholine, reducing muscle stiffness and spasms, and providing relief from chronic pain. For instance, according to the Government of Canada, a Canada-based federal administration, up to 8.3 million Canadians may experience chronic pain by 2025, and it is expected to reach up to 9.0 million by 2030. Therefore, the increasing cases of chronic pain conditions are driving the growth of the myobloc industry.

Key Players In The Global Myobloc Market

Major companies operating in the myobloc market are US WorldMeds LLC.

Regional Insights

North America was the largest region in the myobloc market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Myobloc Market?

The myobloc market consists of sales of single-use vials, injection solutions, and pre-filled syringes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Myobloc Market Report 2026?

The myobloc market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the myobloc industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.